Claims for Patent: 8,603,496

Summary for Patent: 8,603,496

Title:	Compositions and methods for biological remodeling with frozen particle compositions
Abstract:	Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
Inventor(s):	Boyden; Edward S. (Cambridge, MA), Cook; Daniel B. (Seattle, WA), Hyde; Roderick A. (Redmond, WA), Leuthardt; Eric C. (St. Louis, MO), Myhrvold; Nathan P. (Medina, WA), Sweeney; Elizabeth A. (Seattle, WA), Wood, Jr.; Lowell L. (Bellevue, WA)
Assignee:	The Invention Science Fund I, LLC (Bellevue, WA)
Application Number:	12/384,202
Patent Claims:	1. A frozen particle composition, comprising: one or more frozen hydrogen oxide particles coated in at least one biological remodeling agent including one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(.alpha.-hydroxyacid), selectin, or glutaraldehyde. 2. The frozen particle composition of claim 1, further including at least one material that modulates the rate of diffusion or degradation of the at least one biological remodeling agent. 3. The frozen particle composition of claim 1, wherein the at least one biological remodeling agent includes one or more of a blood cell, chondrocyte, endothelial cell, hepatocyte, keratinocyte, myocyte, osteoblast, osteoclast, osteocyte, mesenchymal cell, stem cell, progenitor cell, or fibroblast. 4. The frozen particle composition of claim 1, wherein the at least one biological remodeling agent includes one or more of Type I collagen, Type II collagen, Type III collagen, Type VII collagen, Type X collagen, elastin fibers, or soluble elastin. 5. The frozen particle composition of claim 1, wherein the biological remodeling agent further includes one or more of an angiogenic factor, growth factor, or cytokine. 6. The frozen particle composition of claim 1, wherein the one or more frozen particles include a plurality of frozen particles that are approximately uniform in size, shape, weight, or density. 7. The frozen particle composition of claim 1, further including one or more of a reinforcement agent, abrasive, adhesive agent, therapeutic agent, or explosive materials. 8. A frozen particle composition, comprising: one or more frozen particles including dimethylsulfoxide, cyanoacrylate, polyethylene glycol, and coated in at least one biological remodeling agent including at least one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(.alpha.-hydroxyacid), selectin, or glutaraldehyde. 9. A frozen particle composition, comprising: one or more frozen particles including at least one alcohol, and coated in at least one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(.alpha.-hydroxyacid), selectin, or glutaraldehyde. 10. The frozen particle composition of claim 1, further including at least one detection material. 11. The frozen particle composition of claim 10, wherein the detection material includes at least one of a radioactive element, electronic identification device, luminescent substance, fluorescent substance, magnetic particle, or colorimetric material. 12. The frozen particle composition of claim 7, wherein the at least one reinforcement agent includes at least one of polyaramid, vinylester matrix, metal ceramic, fiberglass, cellulose, broad carbide, aromatic polyamide, nylon, silk, rayon, acetate, modacrylic, olefin, acrylic polymer or copolymer, acrylamide polymer or copolymer, polyester, aromatic polyester, poly-lactic acid, vinyon, saran, spandex, vinalon, aromatic nylon, vinylidene chloride, modal, polybenzimidazole, sulfur, lyocell, orlon, zylon, high-performance polyethylene, polypyridobenzimidazole, vectran, acrylonitrile rubber, diamond, novaculite, borazon, corundum, or zirconia alumina. 13. The frozen particle composition of claim 7, wherein the at least one therapeutic agent includes at least one of an anti-tumor agent, antimicrobial agent, analgesic, anesthetic, anti-inflammatory agent, vaccine, angiogenic factor, apoptotic promoting factor, cytokine, or anti-coagulant. 14. The frozen particle composition of claim 7, wherein the at least one explosive material includes nitroglycerine. 15. The frozen particle composition of claim 7, wherein the at least one adhesive agent includes at least one of an epoxy, urethane, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, or zinc polycarboxylate.

Details for Patent 8,603,496

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-02-26